235 related articles for article (PubMed ID: 36655153)
41. The Threat of Carbapenem-Resistant Gram-Negative Bacteria in Patients with Hematological Malignancies: Unignorable Respiratory Non-Fermentative Bacteria-Derived Bloodstream Infections.
Lu L; Xu C; Tang Y; Wang L; Cheng Q; Chen X; Zhang J; Li Y; Xiao H; Li X
Infect Drug Resist; 2022; 15():2901-2914. PubMed ID: 35693849
[TBL] [Abstract][Full Text] [Related]
42. In vitro Activity of Sitafloxacin and Other Antibiotics against Bacterial Isolates from HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University and Samitivej Sukhumvit Hospital.
Tantisiriwat W; Linasmita P
J Med Assoc Thai; 2017 Apr; 100(4):469-78. PubMed ID: 29912484
[TBL] [Abstract][Full Text] [Related]
43. Trends of Antibiotic Resistance in Multidrug-Resistant Pathogens Isolated from Blood Cultures in a Four-Year Period.
Oksuz L; Altay G; Aktas Z
Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307126
[TBL] [Abstract][Full Text] [Related]
44. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
[TBL] [Abstract][Full Text] [Related]
45. Shifting trends and age distribution of ESKAPEEc resistance in bloodstream infection, Southwest China, 2012-2017.
Yang S; Xu H; Sun J; Sun S
Antimicrob Resist Infect Control; 2019; 8():61. PubMed ID: 30976388
[TBL] [Abstract][Full Text] [Related]
46. Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial.
Giammanco A; Calà C; Fasciana T; Dowzicky MJ
mSphere; 2017; 2(1):. PubMed ID: 28124025
[TBL] [Abstract][Full Text] [Related]
47. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
[TBL] [Abstract][Full Text] [Related]
48. Emergence of
Ibrahim ME; Algak TB; Abbas M; Elamin BK
Exp Ther Med; 2021 Dec; 22(6):1450. PubMed ID: 34721692
[TBL] [Abstract][Full Text] [Related]
49. Comparative Evaluation of Broth Microdilution With Disc Diffusion and VITEK 2 for Susceptibility Testing of Colistin on Multidrug-Resistant Gram-Negative Bacteria.
Anita ; Kumari R; Saurabh K; Kumar S; Kumari N
Cureus; 2023 Dec; 15(12):e50894. PubMed ID: 38259409
[TBL] [Abstract][Full Text] [Related]
50. Frequency and antimicrobial susceptibility of gram-negative bacteria isolated from 2 hospitals in Makkah, Saudi Arabia.
Asghar AH; Faidah HS
Saudi Med J; 2009 Aug; 30(8):1017-23. PubMed ID: 19668881
[TBL] [Abstract][Full Text] [Related]
51. Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabia, 2007-2016.
Balkhy HH; El-Saed A; Alshamrani MM; Alsaedi A; Al Nasser W; El Gammal A; Aljohany SM; Almunif S; Arabi Y; Alqahtani S; Bonnie HB; Alghoribi M; Alothman A; Almohrij SA
Antimicrob Resist Infect Control; 2020 Jan; 9(1):21. PubMed ID: 32000850
[TBL] [Abstract][Full Text] [Related]
52. Molecular characterization of multidrug-resistant Gram-negative pathogens in three tertiary hospitals in Cairo, Egypt.
El-Kholy AA; Girgis SA; Shetta MAF; Abdel-Hamid DH; Elmanakhly AR
Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):987-992. PubMed ID: 31953591
[TBL] [Abstract][Full Text] [Related]
53. Bacteriological profile of wound swab and their antibiogram pattern in a tertiary care hospital, Saudi Arabia.
Alharbi AS
Saudi Med J; 2022 Dec; 43(12):1373-1382. PubMed ID: 36517049
[TBL] [Abstract][Full Text] [Related]
54. Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
Lee YL; Lu MC; Shao PL; Lu PL; Chen YH; Cheng SH; Ko WC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Lee WS; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Liao MH; Hsueh PR
Int J Antimicrob Agents; 2019 Sep; 54(3):318-328. PubMed ID: 31202925
[TBL] [Abstract][Full Text] [Related]
55. Trends in antimicrobial resistance in bloodstream infections at a large tertiary-care hospital in China: a 10-year retrospective study (2010-2019).
Liu C; Xu M; Li X; Dong H; Ming L
J Glob Antimicrob Resist; 2022 Jun; 29():413-419. PubMed ID: 34800707
[TBL] [Abstract][Full Text] [Related]
56. Drug resistance of healthcare-associated pathogenic bacteria and carbapenem-resistant Acinetobacter baumannii homology in the general intensive care unit.
Liu W; Yang Y; Zhang K; Hai Y; Li H; Jiao Y; Xing H; Xu B; Bai H; Zhao Y; Bao H; Zhang S; Ren W; Yang L; Yang H; Tian J; Wang M; Guo T
Ann Palliat Med; 2020 Jul; 9(4):1545-1555. PubMed ID: 32692197
[TBL] [Abstract][Full Text] [Related]
57. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
58. Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns.
Sader HS; Jones RN; Silva JB;
Diagn Microbiol Infect Dis; 2002 Nov; 44(3):281-8. PubMed ID: 12493176
[TBL] [Abstract][Full Text] [Related]
59. Prevalence and antimicrobial resistance among Gram-negative pathogens in Saudi Arabia.
Yezli S; Shibl AM; Livermore DM; Memish ZA
J Chemother; 2014 Oct; 26(5):257-72. PubMed ID: 24669827
[TBL] [Abstract][Full Text] [Related]
60. Antimicrobial Susceptibility Trends Among Gram-Negative Bacilli Causing Bloodstream Infections: Results from the China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2011-2020.
Yan M; Zheng B; Li Y; Lv Y
Infect Drug Resist; 2022; 15():2325-2337. PubMed ID: 35517902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
